Home / Health / China's Cancer Cure: CAR-T Therapy Costs Slashed
China's Cancer Cure: CAR-T Therapy Costs Slashed
7 Sep
Summary
- CAR-T therapy in China costs less than half of US prices.
- Shanghai is a leading destination for innovative CAR-T treatments.
- China has approved more CAR-T products than any other nation.
Shanghai is emerging as a preferred global destination for CAR-T cell therapy, a cutting-edge cancer treatment. Patients from countries like New Zealand and the U.S. are traveling to China, citing lower costs and the country's growing expertise in biotechnology. For instance, a New Zealander received CAR-T treatment in Shanghai for less than half the U.S. price, achieving remission.
China has industrialized CAR-T therapy, even leading with the world's first approved CAR-T treatment for solid tumors. This advancement is exemplified by Shanghai-based CARsgen Therapeutics. While regulatory oversight differs from the U.S., private international hospitals in China focus on approved therapies, ensuring patient safety.
Chinese regulators first approved CAR-T therapy for overseas patients in 2021, and since 2023, Shanghai SinoUnited Hospital has treated dozens of international patients, most now cancer-free. The country's ability to produce tailor-made CAR-T therapies quickly and its comprehensive hospital services, including specialized care, make it an attractive choice.
